山东大学耳鼻喉眼学报 ›› 2025, Vol. 39 ›› Issue (3): 77-80.doi: 10.6040/j.issn.1673-3770.0.2024.514

• 上海市第六人民医院耳鼻咽喉头颈外科献礼“六院120周年”纪念专题 • 上一篇    

先天性纤维蛋白原缺乏症儿童的扁桃体腺样体切除病例分析1例及文献复习

王尧,陈静怡,杨颖超,苏开明   

  1. 上海交通大学医学院附属第六人民医院 耳鼻咽喉头颈外科/上海市睡眠呼吸障碍疾病重点实验室/上海交通大学耳鼻咽喉科研究所, 上海 200233
  • 发布日期:2025-06-04
  • 通讯作者: 苏开明. E-mail:021china@sina.com
  • 基金资助:
    上海交通大学2024年度“医工交叉研究基金”立项(YG2024LC07)

Adenotonsillectomy in a child with congenital fibrinogen deficiency and literature review

WANG Yao, CHEN Jingyi, YANG Yingchao, SU Kaiming   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine / Shanghai Key Laboratory of Sleep Disordered Breathing / Otolaryngology Institute of Shanghai Jiao Tong University, Shanghai 200233, China
  • Published:2025-06-04

摘要: 目的 探讨先天性低纤维蛋白原血症(congenital hypofibrinogenemia, CFD)患者腺样体扁桃体切除术的围手术期管理策略。 方法 回顾性分析1例CFD患者行等离子腺样体扁桃体切除术的围手术期管理,并结合相关文献进行分析。 结果 围手术期纤维蛋白原替代治疗使患者的纤维蛋白原水平从0.23 g/L提升至0.92 g/L,顺利完成腺样体扁桃体切除术。术后患者恢复良好,未出现任何出血并发症。文献检索显示,目前尚未有关于CFD患者行腺样体扁桃体切除术的报道。然而在CFD患者接受其他手术时,纤维蛋白原补充的目标水平通常为0.5~1.0 g/L或适当提高。 结论 CFD患者通过有效的围手术期纤维蛋白原替代治疗,可以安全地进行腺样体扁桃体切除术。

关键词: 先天性纤维蛋白原缺乏症, 扁桃体肥大, 腺样体肥大, 腺样体扁桃体切除术

Abstract: Objective To investigate the perioperative management strategies for adenotonsillectomy in pediatric patients with Congenital Hypofibrinogenemia(CFD). Methods We reviewed and analyzed the perioperative management of a pediatric patient with CFD who underwent adenotonsillectomy using plasma ablation at our hospital, in conjunction with a review of the relevant literature. Results With perioperative fibrinogen replacement therapy, the patient's fibrinogen level was successfully raised from 0.23 g/L to 0.92 g/L, allowing for the safe performance of adenotonsillectomy. The patient recovered well postoperatively without any bleeding complications. A literature search revealed no previous reports of adenotonsillectomy in patients with CFD. However, the target fibrinogen level for supplementation in CFD patients undergoing other surgical procedures is typically 0.5-1.0 g/L or appropriately higher. Conclusion Adenotonsillectomy can be safely performed in pediatric patients with CFD through effective perioperative fibrinogen replacement therapy.

Key words: Congenital hypofibrinogenemia, Tonsil hypertrophy, Adenoidal hypertrophy, Tonsillectomy &, adenoidectomy

中图分类号: 

  • R762.3
[1] Kang YJ, Kim BK, Hong SD, et al. Influence of lingual tonsillar volume in patients with obstructive sleep apnea[J]. Life, 2022, 12(11): 1920. doi:10.3390/life12111920
[2] 史保院, 史丽, 殷凤芳. 儿童腺样体肥大经口行鼻内镜下吸切术[J]. 山东大学耳鼻喉眼学报, 2007, 21(3): 221-223. doi:10.3969/j.issn.1673-3770.2007.03.012 SHI Baoyuan, SHI Li, YIN Fengfang. Endoscopic adenoidectomy for hypertrophic adenoid with micro-stryker instruments[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2007, 21(3): 221-223. doi:10.3969/j.issn.1673-3770.2007.03.012
[3] Mitchell RB, Archer SM, Ishman SL, et al. Clinical practice guideline: tonsillectomy in children(update)-executive summary[J]. Otolaryngol Head Neck Surg, 2019, 160(2): 187-205. doi:10.1177/0194599818807917
[4] Randel A. AAO-HNS guidelines for tonsillectomy in children and adolescents[J]. Am Fam Physician, 2011, 84(5): 566-573
[5] 廖湘成, 张珊珊, 阳子骥, 等. 先天性异常纤维蛋白原血症家系调查及输血[J]. 中国实验血液学杂志, 2023, 31(5): 1469-1474. doi:10.19746/j.cnki.issn1009-2137.2023.05.034 LIAO Xiangcheng, ZHANG Shanshan, YANG Ziji, et al. A family with congenital dysfibrinogenemia and blood transfusion[J]. Journal of Experimental Hematology, 2023, 31(5): 1469-1474. doi:10.19746/j.cnki.issn1009-2137.2023.05.034
[6] Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association, et al. Consensus of Chinese expert on the diagnosis and treatment of rare bleeding disorders(version 2021)[J]. Zhonghua Xue Ye Xue Za Zhi, 2021, 42(2): 89-96. doi:10.3760/cma.j.issn.0253-2727.2021.02.001
[7] de Moerloose P, Neerman-Arbez M. Congenital fibrinogen disorders[J]. Semin Thromb Hemost, 2009, 35(4): 356-366. doi:10.1055/s-0029-1225758
[8] Czajkowska S, Rupa-Matysek J, Brzezińska J, et al. Transfusion of fibrinogen concentrate before dental extractions in patients with afibrinogenemia: a narrative review supported by a case report with a proposed treatment protocol[J]. Blood Transfus, 2023, 21(2): 168-175. doi:10.2450/2022.0037-22
[9] Saes JL, Laros-van Gorkom BAP, Coppens M, et al. Pregnancy outcome in afibrinogenemia: are we giving enough fibrinogen concentrate? A case series[J]. Res Pract Thromb Haemost, 2020, 4(2): 343-346. doi:10.1002/rth2.12300
[10] Yan J, Luo ML, Xiang LQ, et al. Congenital dysfibrinogenemia in major surgery: a description of four cases and review of the literature[J]. Clin Chim Acta, 2022, 528: 1-5. doi:10.1016/j.cca.2022.01.009
[11] Abi Habib P, Goetzinger K, Turan OM. Placenta accreta spectrum conservative management and coagulopathy: case series and systematic review[J]. Ultrasound Obstet Gynecol, 2024, 63(6): 731-737. doi:10.1002/uog.27547
[12] Khayat CD, Lohade S, Zekavat OR, et al. Efficacy and safety of fibrinogen concentrate for perioperative prophylaxis of bleeding in adult, adolescent, and pediatric patients with congenital fibrinogen deficiency: FORMA-02 and FORMA-04 clinical trials[J]. Transfusion, 2022, 62(9): 1871-1881. doi:10.1111/trf.17029
[13] Casini A, Abdul Kadir R, Abdelwahab M, et al. Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen[J]. J Thromb Haemost, 2024, 22(5): 1516-1521. doi:10.1016/j.jtha.2024.01.008
[1] 罗露,周恩,肖旭平,林志强,方志杰,吕晓虹. 等离子点状激发技术在儿童OSA扁桃体腺样体切除术联合围手术期快速康复中的应用[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 26-30.
[2] 赵云,滕支盼,李琦,沈小飞. 儿童腺样体扁桃体切除后圆枕增生26例[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 43-48.
[3] 朱雅欣,刘峰,关建,殷善开. 儿童扁桃体腺样体肥大组织淋巴细胞改变的研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 62-67.
[4] 崔佳文,王怡超,刘鲲鹏,王树霞,胡丽君,顾非. 推拿改善腺样体肥大患儿呼吸暂停低通气指数的临床观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 133-138.
[5] 倪守洁,邹娟娟,郭瑞祥,韩莹莹,金霄雪,李延忠,王岩. 儿童头颅侧位片测量参数对腺样体肥大诊断价值的研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 39-44.
[6] 王兴鑫,杨欣雨,郑晓军,丁麟,盛亚文,毕晓云,杨继国. 穴位贴敷疗法治疗小儿腺样体肥大1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 122-124.
[7] 张丰珍, 王桂香, 魏沄沄, 张亚梅, 赵靖, 王华, 李宏彬, 李晓丹, 张杰. 合并轻度出血性疾病的扁桃体和(或)腺样体切除术患儿围手术期管理[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 66-72.
[8] 金霄雪,韩莹莹,郭瑞祥,倪守洁,邹娟娟,王岩,李延忠. 替牙期扁桃体伴腺样体肥大患儿过敏因素与颌面畸形的相关性[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 45-50.
[9] 师晓丽, 牟鸿. 多学科联合诊治重度儿童阻塞性睡眠呼吸暂停综合征并发肺动脉高压1例[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 116-119.
[10] 袁晨阳, 刘燕, 房振胜. 儿童阻塞性睡眠呼吸暂停低通气综合征对肺功能的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 143-148.
[11] 冯晨,郭瑞祥,王岩. 等离子射频消融术在儿童阻塞性睡眠呼吸暂停中的应用和进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 16-21.
[12] 吴华,孙永明,郑建华,蔡雪花. 腺样体消融联合鼓膜打孔术治疗儿童腺样体肥大合并分泌性中耳炎55例[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 71-75.
[13] 谷婷婷,刘岩,张悦,于丹,文连姬. 内舒拿联合孟鲁司特钠治疗腺样体肥大的Meta分析[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 47-55.
[14] 张立强. 儿童鼻窦炎与腺样体肥大的关系[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 25-28.
[15] 吴兆坤,朱新华. 腺样体扁桃体切除术治愈儿童阻塞性睡眠呼吸暂停综合征的偏误研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 148-152.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!